Clinical Indicators for Coders/CDI The following indicators, when present in physician documentation, laboratory values, or diagnostic reports, support assignment of a Crohns disease diagnosis and may trigger CDI queries for greater specificity: When imaging or operative reports document a fistula, abscess, or bowel obstruction in a patient with known Crohns disease, and the attendings Crohns diagnosis code lacks a complication specifier, query the provider: Does the patients current admission involve Crohns disease with [fistula / abscess / obstruction / rectal bleeding] as a complication of the Crohns, a separate condition, or both? This distinction determines whether to code K50.x13, K50.x14, K50.x12, or K50.x11 vs
Morning administration aligns with natural circadian rhythms and supports daytime energy metabolism and fat oxidation
The combination is used in in vitro research examining potential additive or synergistic effects at the molecular level
Common J-code pairings with CPT 96372: J3301 (triamcinolone acetonide) corticosteroid injections for inflammatory conditions J3420 (vitamin B12 / cyanocobalamin) B12 deficiency or supplementation injections J1071 (testosterone cypionate) testosterone replacement therapy injections J0897 (denosumab) subcutaneous biologic injection for osteoporosis or treatment-induced bone loss J0702 (betamethasone acetate/sodium phosphate) corticosteroid for acute inflammatory conditions J-code coverage varies by payer and formulary
GLOW Peptide Dosage Calculator and Protocol Guide July 23, 2026 Regulatory Update : The FDA Pharmacy Compounding Advisory Committee voted to recommend adding BPC-157 and TB-500 to the 503A Bulks List, against FDA staff who had recommended against listing